Clinical Trial Update: To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating granulocyte colony-stimulating factor versus standard medical therapy in decompensated cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Decompensated Cirrhosis

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Sir Ganga Ram Hospital | Conditions: Cirrhosis | Phase 3 | Status: COMPLETED